Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vilazodone in the Treatment of Social Anxiety Disorder: A Double Blind Study

NCT01712321 is registered in ClinicalTrials.gov with The Medical Research Network as lead sponsor.

NCT NCT01712321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01712321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vilazodone in the Treatment of Social Anxiety Disorder: A Double Blind Study
Lead sponsor
The Medical Research Network
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2012
Completion date
April 30, 2014
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder